Protagonist Therapeutics (PTGX)

• Market cap: $5.65B
• 1 day: 0.53%
• 5 days: 4.61%
• 1 month: 20.05%
• 3 months: 58.52%
• 6 months: 94.57%
• Year to date: 131.76%
• 1 year: 101.52%
• 5 years: 278.78%
• 10 years: 672.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 128